Alignment of the amino terminal amino acid sequence of human cytochrome c oxidase subunits I and II with the sequence of their putative mRNAs by Chomyn, Anne et al.
Volume 9 Number 4 1981 Nucleic Acids Research
Alignment of the amino terninal amino acid sequence of human cytochrome c oxidase subunits I
and II with the sequence of their putative mRNAs
Anne Chomyn, Michael W.Hunkapiller and Giuseppe Attardi
Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA
Received 1 December 1980
ABSTRACT
Thirteen of the first fifteen amino acids from the NH2-terminus of the primary
sequence of human cytochrome c oxidase subunit I and eleven of the first twelve amino
acids of subunit II have been identified by microsequencing procedures. These
sequences have been compared with the recently determined 5'-end proximal sequences
of the HeLa cell mitochondrial mRNAs and unambiguously aligned with two of them.
This alignment has allowed the identification of the putative mRNA for subunit I, and
has shown that the initiator codon for this subunit is only three nucleotides away from
the 5'-end of its mRNA; furthermore, the results have substantiated the idea that the
translation of human cytochrome c oxidase subunit II starts directly at the 5'-end of its
putative mRNA, as had been previously inferred on the basis of the sequence homology
of human mitochondrial DNA with the primary sequence of the bovine subunit.
INTRODUCTION
Human cytochrome c oxidase has been recently isolated from placental material
and its subunit composition, characterized.' Furthermore, it has been shown that, in
HeLa cells, as in yeast and Neurospora crassa,2 the three largest among the seven
polypeptide components of the enzyme are synthesized in mitochondria, and are in fact
among the major mitochondrial translation products in these cells.' Previous evidence
indicating that all the mRNAs utilized for mitochondrial translation in HeLa cells are
endogenous3'4 had given support to the idea that the three mitochondrially synthesized
subunits of the human enzyme are encoded in mitochondrial DNA (mtDNA), as is true
for the homologous subunits of the yeast enzyme.5'6 The recent progress in the
sequence analysis of human mtDNA and mitochondrial RNA has made it possible to
verify this idea and to investigate in detail the mtDNA sequences coding for the three
subunits. Thus, the gene for cytochrome c oxidase subunit II (COII) has been mapped in
human mtDNA on the basis of the homology existing between the amino acid sequence
of subunit II of the bovine enzyme and an amino acid sequence encoded in a stretch of
human mtDNA.7 A striking result of this analysis has been that the reading frame for
human COII appears to be joined end-to-end, on its 5'-side, to the tRNAAsp gene. More
recently, a sequencing analysis of the mitochondrial poly(A)-containing RNA mapping in
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the region of the COIl gene [RNA 16, in the classification of Amalric et al.8(Fig. 1)19
has revealed that this RNA starts directly with the presumptive initiator codon of
COn.10 This close proximity of the initiator codon to the 5'-end of the mRNA may be a
common feature of human mitochondrial mRNAs. A recent sequence analysis has shown
that nine of the ten identified mitochondrial heavy (H)-strand coded mRNAs from HeLa
cells have a triplet AUG or AUA (AUA is also a methionine codon in human
mitochondria) at or very close to their 5'-end;12913 in the case of the tenth mRNA,
*which starts with an AUU, there is suggestive evidence that this triplet as well
functions as an initiator codon for the corresponding polypeptide.12 In the present
work, we have provided direct evidence that the AUG following the tRNAAsp gene is
indeed the initiator codon for the amino acid sequence of human cytochrome c oxidase
subunit II. Furthermore, we have identified the mRNA for cytochrome c oxidase
subunit I (COI) and shown that, in this RNA (RNA 9), the initiator codon (AUG) is
located three nucleotides from the 5'-end. While this work was in progress, we learned
from'personal communication that F. Sanger and collaborators have identified in human
mtDNA the reading frame of COI by comparison with the amino acid sequence of the
bovine subunit.14
5 6 7 8 9kbfrom
the origin
Asn Cys
Ala \/Tyr Ser
__ p ~~~~~~~~~~L
I ~~~~H
Trp Asp Lys
6
12 16 14
_ ~~~~~~~COI
9
CO I
Figure 1. Portion of the HeLa cell mtDNA genetic and transcription map illustrating
the COI and COII gene region. The diagram shows the precise positions of the H-strand
transcripts corresponding to the COI and COII genes as well as the positions of several
H-strand (m) and L-strand coded (0) tRNA genes (modified from ref. 9). The positions
and identities of the tRNA genes were derived from the mtDNA sequence (ref. 7, 14;
F. Sanger and B. Barrell, personal communication). The hatched bars reprgs ent the
H-strand transcripts numbered according to the classification of Amalric et al. The
scale in the upper portion of the diagram measures the distance in kilobases from the
origin of replication in the direction of H-strand transcription (indicated by the
rightward arrow in the lower part of the Figure). H: heavy strand; L: light strand.
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MATERIALS AND METHODS
Materials. Sodium dodecyl sulfate (SDS), acrylamide, bisacrylamide, N,NN',N'-
tetramethylethylenediamine (TEMED), ammonium persulfate, and SM2 beads were
purchased from Biorad; "Ultra-pure" urea, from Schwarz-Mann; and all the other
reagents, from Sigma.
Isolation of Subunits. Cytochrome c oxidase was isolated according to the
procedure of Hare et al. 1 from human placenta and from human heart tissue derived
from autopsy material. Fractionation on SDS/urea polyacrylamide gel of the subunits of
the purified enzyme was carried out as described, with the following modification. The
enzyme solution, after the last purification step and prior to gel electrophoresis, was
shaken with SM2 beads: this step had the purpose of reducing, by adsorption to the
beads, the concentration of Triton X-100,15 which limits considerably the amount of
enzyme that can be loaded on a preparative SDS/urea gel.
For the isolation of the individual subunits for sequence analysis, two procedures
were used: in one procedure, the entire gel was fixed, stained and destained,16 and gel
slices corresponding to the COI and COII bands were excised, neutralized with
phosphate buffered saline and stored frozen at -20°C until use; in the other procedure, a
longitudinal slice cut out of each lane containing the human enzyme was stained,
destained, and used as a guide in cutting bands of the frozen, unstained gel
corresponding to COI and COII. Protein was eluted from the stained gel fragments by
shaking in 8 M urea, 6% SDS, 0.1 M phosphoric acid, adjusted to pH 8 with Tris, for two
days at 250C, and from unstained gel slices according to the method of Anderson et
al.17 The protein was dialyzed first against 0.15 M NaCl, 0.1% SDS for 50 h; then
against 0.1% SDS for 19 h; and finally against 0.02% SDS for 44 h. The dialyzing
solutions also contained 0.01 M NaHCO3 and 0.001 M dithiothreitol or 0.001 M
8-mercaptoethanol or 0.01 M thioglycolate. The protein solution was finally lyophi-
lized.
Sequence Analysis. Since the bovine COI and COII are blocked at their NH2-
termini by formyl groups, 18,19 we anticipated the presence of blocked NH2-termini in
20~~~~~~~~~~the human subunits as well. Thlerefore, human COI and COII were exposed to deblocking
conditions, i.e., 0.5 M HC1 in methanol,20 for two or three days at 25°C, and then
lyophilized; in order to hydrolyze glutamyl and aspartyl methyl esters which may have
formed during the deblocking treatment,19 the samples were dissolved in 0.5 M NH4OH
and incubated overnight at room temperature. Automated Edman degradation was
performed on 5 to 25 pg of protein at a time in a spinning cup sequenator designed for
sequencing picomole to nanomole quantities of protein.21 Phenylthiohydantoin (Pth)
amino acids were identified by high pressure liquid chromotagraphy (HPLC) on a DuPont
Zorbax CN column.
869
Nucleic Acids Research
RESULTS
Isolation of cytochrome c oxidase subunits I and H. Figure 2 shows the electro-
phoretic pattern in an SDS-urea polyacrylamide gel of human cytochrome c oxidase
purified from human placenta according to the method of Hare et al. 1 up to the DEAE-
cellulose chromatography step (lane b), and, for comparison, the pattern of the bovine
enzyme purified by the Capaldi and Hayashi procedure22 (lane a). The bovine enzyme
exhibits the typical seven subunits, with a small amount of high molecular weight
contaminants and, in addition, three contaminants reproducibly observed in this type of
preparation,122 one migrating between subunits IV and V and two others between
subunits V and VI (they presumably correspond to the impurities denoted 'a', lb' and 'ct,
(a) (b) (C) (d) (e) (f)
I-}sOx s I (43.6) I---g
:::: .20 '4'.
m - (5.6)
M I[ (3.7)
Figure 2. Purification of human cytochrome c oxidase subunits I and HI. (a) and (b):
electrophoretic patterns in SDS-urea polyacrylavide gels of beef heart cytochrome c
oxidase purified accordiY9 to Capaldi and Hayashi (a), and of human enzyme purified
according to Hare et al. up to the stage of DEAE-cellulose chromatography (b); the
numbers near the human subunits represent their previously estimated molecular
weights in kilodaltons;1 (c) and (f): electrophoretic behavior of human subunits I1(c) and
HI (f), eluted from preparative gels as described in Materials and Methods, and rerun on
an SDS-urea-po1yacrylamide gel in parallel with a beef heart enzyme marker [(d) and(e)J.
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respectively, in Capaldi et al.).23 The human enzyme pattern shows also seven subunits,
which migrate identically or similarly to the beef heart enzyme subunits; as previously
reported,1 human subunit II has an electrophoretic mobility distinctly higher than the
bovine COIH, while human subunit I migrates somewhat slower and subunit IV somewhat
faster than the homologous beef heart components. Indicated in lane b are the apparent
molecular weights of the seven human subunits, as previously estimated.1 There is a
contaminant, reproducibly observed, migrating slightly slower than subunit HI,1 another
contaminant migrating slightly faster than subunit IV and small amounts of contami-
nants with mobilities similar to those of the impurities, mentioned above, present in the
beef heart enzyme. Although most of these contaminants can be removed by running
the DEAE-cellulose purified enzyme through a sucrose gradient, in the present work,
this further step of purification was not performed, in order to avoid losses, since
subunits I and II appeared to be well resolved from any contaminant. The bands
corresponding to these subunits were excised from stained or unstained gels, and the
subunits, eluted and concentrated. In order to check the purity of the subunits and to
obtain a rough estimate of the amount recovered in the elution, a portion of each
subunit preparation was rerun on a gel in parallel with a known amount of beef heart
enzyme marker. Figure 2 shows the electrophoretic behavior of subunit I eluted from
an unstained gel (lane c) and subunit II eluted from a stained gel (lane f). No
contamination of either of the two subunits by other subunits or extraneous proteins is
observed; furthermore, the two subunits migrated with the same mobilities they have in
the whole enzyme sample, as can be judged from comparison with the behavior of the
beef heart enzyme subunits (lanes d and e). The yield of protein extracted from unfixed
and unstained gel (40 to 50%) was greater than the yield from fixed and stained gels (420%).
Protein Sequencing Analysis. The limited amounts of purified subunits available
demanded the use of microsequencing procedures.21 In order to remove the formyl
group which was expected to block the NH -termini of human COI and COII, as is the
case for the homologous bovine subunits, the two human subunits eluted from the
preparative gels were treated, prior to sequencing, with methanolic hydrochloric acid
20~~~~~~~~~~~~~~~~for two or three days.2 That human COT and COII indeed have their NH2-termini
blocked is indicated by the observation that a shorter deblocking treatment (2 h) gave,
for an equivalent amount of protein, a considerably lower yield (<5% versus 25-30%) of
Pth-amino acid at each cycle of the automated Edman degradation. In view of the
limited efficiency of the deblocking treatment, the purity of the protein analyzed was
essential, since any contaminating protein without a blocked NH2-terminus would form
the first Pth-derivative more readily and would therefore be favored in its detection
also in the following sequencing cycles. Figure 3a shows the amino terminal amino acid
sequence of human COI derived after 15 cycles. All the first 15 amino acids, except the
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(a)
1 5 10 15
CO I F-Met-PPhe - Ala - Asp - Arg -Trp - Leu - Ptie - (n.d.)- (n.d.)- Asn - His - Lys - Arg - ne.
RNA 9 5' CUGAUGUUCGCCGACCGUUGACUAUUCUCUACAAACCACAAAGACA ................3'
1 10 20 30 40
(b)
1 5 10
CO IdI-(.d-Ala - His - Ala-Ala-Gsln -Val -Gly -Leu - Gln -Asp-Ala.
RNA 16 5' AUGGCACAUGCAGCGCAAGUAGGUCUACA...............3'
1 10 20
Figure 3. Alignment of the amino terminal amino acid sequence of human cytochrome c
oxidase subunits I and II with the 5'-end proximal sequence of RNAs 9 and 16,
respectively (n.d.: not determined). The RNA sequences were determined as described
elsewhere; the 'd itification of the pyrimidines as U or C was made on the basis of the
DNA sequence.1
ninth and tenth, could be identified. At the NH2-terminus, a methionine was detected
and was interpreted to have derived from formyl-methionine. Figure 3b shows the
amino terminal sequence of human COII obtained after 12 cycles: all the first 12 amino
acids, except the first, were identified.
Correlation of Protein and RNA Sequences. A comparison of the amino terminal
amino acid sequences of human COI and COII determined here with the 5'-end proximal
sequences of the ten presumptive mitochondrial H-strand coded mRNAs identified in
HeLa cells912,13 has allowed the unambiguous alignment of the two protein sequences
with two RNA sequences. In fact, a screening of all RNA sequences13 reveals that only
the 5'-end proximal sequence of RNA 9 (Fig. 3a) could fit the COI amino terminal amino
acid sequence. RNA 5, for which only a partial sequence of a very short 5'-end
proximal region had been determined (AY---Y--G, where Y stands for pyrimidine), due
to the extremely minute amounts of material available,13 could also be aligned with the
COI amino terminal amino acid sequence on the basis of these limited data; however,
the corresponding DNA sequence, identified first from transcription mapping data9"12
and then by alignment with the human mtDNA sequence (F. Sanger and B. Barrell,
personal communication) is ATAACCATG, which would not fit the observed amino acid
sequence. The 5'-end proximal sequence of all other putative mitochondrial mRNAs
showed varying degrees of incompatibility with the COI sequence, with 2 out of 4 to 11
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out of 13 inconsistencies in different cases (computed using the human mitochondrial
genetic code"1 and the experimentally determined RNA sequences, with the pyrimidine
undetermined).10'13 In Figure 3a it should be noticed that the sixth amino acid from
the amino terminal of COI, i.e., tryptophan, corresponds in the RNA sequence to UGA,
an observation which confirms the previously reached conclusion about the use of the
'opal' termination codon as tryptophan codon in human mitochondria.7 From the RNA 9
sequence it appears that the ninth and tenth codons are a serine and threonine codon,
respectively. The failure to identify the ninth and tenth amino acid in the
microsequencing analysis is presumably explained by the fact that the Pth derivatives of
these amino acids are obtained in much lower yields than those of the other amino
acids, and are therefore more difficult to detect when they are present in low
concentrations.
As concerns the COII amino terminal amino acid sequence, the only 5'-end
proximal RNA sequence with which it could be aligned was that of RNA 16; this RNA
had been previously identified as the putative COII mRNA on the basis of mapping data
and of an alignment of the RNA sequences with the DNA sequence of the COIl
gene.7v910 All other RNA sequences exhibited from 8 out of 11 to 5 out of 5
inconsistencies with the COIl sequence.
DISCUSSION
The unusual features of the 5'-end terminal sequences of human mitochondrial
mRNAs, which all appear to start at the initiator codon or to have only a few
nucleotides preceding this codon,12"13 have made it possible, in the present work, to
align the amino terminal amino acid sequence of human COI and COIl with the
corresponding RNA sequence. For subunit I, this alignment has led to the identification
of RNA 9 as its putative mRNA. This RNA is one of the three, among the mRNAs
identified and mapped in HeLa cell mtDNA, which is long enough to accommodate the
COI coding sequence,9 and the only mRNA whose 5'-end proximal sequence could be
aligned with the amino terminal amino acid sequence determined here. The apparent
lack of intervening sequences in animal cell mitochondrial genes9'24 strongly suggests
that the whole COI sequence is encoded in RNA 9. The sequences coding for this RNA
are located in the HeLa cell mtDNA map between coordinates 34/100 and 44/100
(relative to the origin taken as 0/100), and are flanked, on the 5'-side, by a group of four
L-strand tRNA genes and, on the 3'-side, by the tRNASer gene of the H-strand9
(Fig. 1). From the human mtDNA transcription map9 it appears that the sequences
coding for poly(A)-containing RNA 6 overlap the RNA 9 coding stretch, extending
beyond this on the 5'-side, so as to include the sequences complementary to the four
L-strand tRNA genes, and coinciding with the RNA 9 coding sequence at the 3'-end
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(Fig. 1). However, there are good reasons for believing that RNA 6 is not utilized in
vivo as COI mRNA. Rather, this RNA, because of its presence in only marginal
amounts in partially purified polysomal structures and of its relatively short half-
life,3'4 is very probably a precursor of RNA 9, which would derive from RNA 6 by
removal of the 5'-end proximal stretch containing the sequences complementary to the
four L-strand coded tRNA species. The synthesis of this RNA segment on the 5'-side of
RNA 9, which extends as far as to reach the 3'-end of the tRNATrP (Fig. 1), is
presumably a result of the mode of H-strand transcription: this transcription in fact,
appears to occur in the form of a single molecule, which is processed by precise
endonucleolytic cleavages before and after each tRNA sequence to yield the mature
products or, in some cases, processing intermediates, like the putative precursors of the
rRNAs (RNA 4) and of RNA 9 (RNA 6).9,12925
An interesting result of the alignment of the amino terminal amino acid sequence
of human COI with RNA 9 is that the initiator codon for this polypeptide is situated at
three nucleotides from the 5'-end. Similarly, the alignment of the amino terminal
sequence of human COII with RNA 16 has provided direct evidence that the 5'-terminal
AUG of this RNA is indeed the initiator codon for the polypeptide, as had been
previously inferred on the basis of the sequence homology of human mtDNA with the
primary sequence of the bovine subunit.7"10 Other observations, based on a comparison
with the sequences of the yeast cytochrome b26 and cytochrome c oxidase subunit IH
(corn)6 genes, have recently led to the assignment of the cytochrome b and com genes
to two reading frames in mtDNA27 and to the identification of the corresponding
poly(A)-containing RNAs, RNA 11 and RNA 15,9,25 as cytochrome b and COII mRNA,
respectively: in these RNAs as well, the AUG found immediately at the 5'-end appears
to be the initiator codon for the corresponding polypeptide.25 Thus, it seems reasonable
to extrapolate from these results to interpret the terminal or subterminal AUG, and
probably also the 5'-proximal AUA or AUU, of the other H-strand coded mRNAs
likewise as initiator codons.12
The observation that most, if not all human mitochondrial mRNAs either start
directly at the initiator codon or have only a few nucleotides preceding this codon
indicates that in these mRNAs, in contrast to the known prokaryotic and eukaryotic
mRNAs,28 30 ribosome attachment can occur with adequate efficiency in the absence
of a 5'-noncoding stretch. It is conceivable that special features of human and, in
general, mammalian mitochondrial ribosomes or some initiation factor make them
suitable for recognizing and binding directly to a terminal or subterminal initiator
codon. It is also conceivable that the secondary structure of these mRNAs is such that
it would exclude all internal sites containing AUG, AUA or AUU codons, exposing only
the terminal or subterminal initiator codons.
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The present results also have relevance to the question of the possible processing
of the cytochrome c oxidase subunits. The putative reading frame for subunit one in
human mtDNA is 1539 nt long (F. Sanger and B. Barrell, personal communication), i.e.,
about 40% longer than required to account for the molecular weight of this subunit, as
estimated from its electrophoretic mobility in SDS-urea polyacrylamide gels (43,600
daltons).1 Similarly, the reading frame for subunit II is 681 nt long,7 i.e., about 35%
longer than expected for a polypeptide with an estimated molecular weight of 20,100
daltons.1 While this difference is probably due to a great extent to the inaccuracy of
molecular weight determinations of hydrophobic proteins in SDS-urea polyacrylamide
gels, the question has to be posed whether the above mentioned reading frames code for
precursors destined to be processed to mature products by removal of amino- or
carboxyl-terminal segments. In yeast, there is suggestive evidence from in vitro
synthesis experiments31'32 and from DNA sequence data33 that the COII polypeptide
may be synthesized in form of a precursor with a transient leader sequence. In
Neurospora crassa, there is likewise evidence for the occurrence of amino terminally
extended precursor polypeptides for COI and COII.34 The results presented here,
indicating that in human cytochrome c oxidase the amino terminal methionine of the
mature COI is blocked, presumably by a formyl group, and furthermore that this
methionine corresponds to the second codon of the putative COT mRNA, tend to exclude
the possibility that any processing of the newly synthesized COI polypeptide occurs at
the NH2-terminus. However, any definitive conclusion about the possible occurrence of
longer precursors of human COI must await the determination of the sequence at the
COOH-terminus of the mature subunit. In the case of the COII of the beef heart
enzyme, a perfect correspondence has been found between the length of the polypeptide
and that of the homologous human mtDNA sequence,7 a finding which argues strongly
against the existence of longer precursors of the bovine subunit. The present results
extend the above conclusion to the human COLT as concerns the NH2-terminus; if
further work will prove that the same applies to the COOH-terminus, a factor other
than a difference in the length of the polypeptide chain must be responsible for the
higher electrophoretic -mobility consistently observed for the human COII as compared
to the bovine subunit.1
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